Pharma Research Library | Pharma Info Index Research | Innovation | Opportunities |
Sravani K*, B. Kumar
Department of Pharmacy Practice, Ratnam institute of Pharmacy, Pidathapolur (V&P), Muthukur (M), SPSR Nellore district-524 346
A B S T R A C T
Rheumatoid Arthritis has emerged as important clinical and public health problem Rheumatoid arthritis is an autoimmune disease that causes chronic inflammation of the joints. Autoimmune diseases are illnesses that occur when the body’s tissues are mistakenly attacked by their own immune system. The current objective of study is to screen the prescription trends in Rheumatoid Arthritis patients. In this study, 80 cases were collected in which determines the therapy was administered for Rheumatoid Arthritis patients rules out generic or essential drug prescribing. The study was Simple Prospective observational study which was carried out for a period of six months. In this study 80 cases involving drugs administration were included. Maximum numbers of patients were in the age group of 41- 60 years (63.75 %) and among 80 cases, males constituted 35 (43.75 %) and females 45 (56.25%). Out of 80 patients 27 patients (33.75 %) patients were found suffering with co morbid concurrent illness hypertension followed by cardio complications associated other comorbidities are Diabetes Mellitus, Spondylosis, Fever, Dyslipidemia, Acute Pancreatitis, Hypothyroidism and Asthma. The percentage of patients on Rheumatoid Arthritis immunotherapy (32, 29.12%) and combination therapy (78, 70.98%). The study reveals that human Hydroxychloroquin is the most prescribe in monotherapy. Clinical effectiveness of therapy is influenced by prescriber agent selection and therapy changes as well patient’s adherence with prescribed drug regimens.
Keywords: Prescription patterns, Rhematoid Arthritis, Generic Drugs and Therapy.
